Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma

Pharmacogenetics and Genomics

Volumn 18, Issue 5, 2008, Pages 373-382

  Poon, Audrey H ^a,c   Tantisira, Kelan G ^a,c   Litonjua, Augusto A ^a,b,c   Lazarus, Ross ^a,c   Xu, Jingsong ^c   Lasky Su, Jessica ^a,d,e   Lima, John J ^f,g   Irvin, Charles G ^f,h   Hanrahan, John P ⁱ   Lange, Christoph ^c,d   Weiss, Scott T ^a,c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f American Lung Association   (United States)

^g NEMOURS CHILDREN S CLINIC   (United States)

^h UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

ⁱ SUNOVION PHARMACEUTICALS INC   (United States)

Author keywords

2 adrenergic receptor agonist; Asthma; Bronchodilator response; Corticotropin releasing hormone receptor 2; Genetics; Polymorphism

Indexed keywords

BRONCHODILATING AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; METHACHOLINE; MONTELUKAST; PLACEBO; SALBUTAMOL; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CHILD; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ALBUTEROL; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GENE FREQUENCY; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PLACEBOS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESPIRATION; THEOPHYLLINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 42149193094     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3282fa760a     Document Type: Article

References (34)

1. Raby BA, Weiss ST. Beta2-adrenergic receptor genetics. Curr Opin Mol Ther 2001; 3:554-566.
2. Johnson M. Molecular mechanisms of beta(2)-adrenergic receptor function, response, and regulation. J Allergy Clin Immunol 2006; 117:18-24; quiz 25.
3. Drazen JM, Silverman EK, Lee TH. Heterogeneity of therapeutic responses in asthma. Br Med Bull 2000; 56:1054-1070.
4. Silverman EK, Kwiatkowski DJ, Sylvia JS, Lazarus R, Drazen JM, Lange C, et al. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J Allergy Clin Immunol 2003; 112:870-876.
5. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000; 97:10483-10488.
6. Lima JJ, Thomason DB, Mohamed MH, Eberle LV, Self TH, Johnson JA. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther 1999; 65:519-525.
7. Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 2005; 171:563-570.
8. Tsai HJ, Shaikh N, Kho JY, Battle N, Naqvi M, Navarro D, et al. Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum Genet 2006; 119:547-557.
9. Woszczek G, Borowiec M, Ptasinska A, Kosinski S, Pawliczak R, Kowalski ML. Beta2-ADR haplotypes/polymorphisms associate with bronchodilator response and total IgE in grass allergy. Allergy 2005; 60:1412-1417.
10. Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100:3184-3188.
11. Tantisira KG, Small KM, Litonjua AA, Weiss ST, Liggett SB. Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways. Hum Mol Genet 2005; 14:1671-1677.
12. Moffatt JD, Lever R, Page CP. Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice. Faseb J 2006; 20:1877-1879.
13. Wu Y, Zhou H, Xu Y, Li S. Enhanced expression of urocortin in lung tissues of rats with allergic asthma. Biochem Biophys Res Commun 2006; 341:532-540.
14. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000; 24:403-409.
15. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000; 24:410-414.
16. Meyer AH, Ullmer C, Schmuck K, Morel C, Wishart W, Lubbert H, et al. Localization of the human CRF2 receptor to 7p21-p15 by radiation hybrid mapping and FISH analysis. Genomics 1997; 40:189-190.
17. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, de Souza EB. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 1996; 137:72-77.
18. Catalano RD, Kyriakou T, Chen J, Easton A, Hillhouse EW. Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol Endocrinol 2003; 17:395-410.
19. Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev 2006; 27:260-286.
20. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Childhood Asthma Management Program Research Group. Control Clin Trials 1999; 20:91-120.
21. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000; 343:1054-1063.
22. Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004; 13:1353-1359.
23. The American Lung Associations Asthma Clinical Research Centers. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. Am J Respir Crit Care Med 2007; 175:235-242.
24. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-907.
25. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med 2006; 100:616-621.
26. Sun X, Ding H, Hung K, Guo B. A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. Nucleic Acids Res 2000; 28:E68.
27. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res 1993; 21:3761-3766.
28. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265.
29. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70:425-434.
30. Finney PA, Belvisi MG, Donnelly LE, Chuang TT, Mak JC, Scorer C, et al. Albuterol-induced downregulation of Gsalpha accounts for pulmonary beta(2)-adrenoceptor desensitization in vivo. J Clin Invest 2000; 106:125-135.
31. Shore SA. Cytokine regulation of beta-adrenergic responses in airway smooth muscle. J Allergy Clin Immunol 2002; 110 (6 Suppl):S255-S260.
32. Selbie LA, Hill SJ. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends Pharmacol Sci 1998; 19:87-93.
33. 2+. Biochem J 2003; 374 (Pt 2):281-296.
34. Mathias RA, Gao P, Goldstein JL, Wilson AF, Pugh EW, Furbert-Harris P, et al. A graphical assessment of P-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q. BMC Genet 2006; 7:38.